drugset / Trial / NCT00627575

AED/Statin Interaction Study

NCT00627575

Phase 1 Completed 119 enrolled GlaxoSmithKline
Non-randomizedParallel-groupOpen-labelTreatment

Summary

This study will evaluate the amount of the cholesterol-lowering drug atorvastatin available in the bloodstream, when taken together with the anti-seizure drugs lamotrigine or phenytoin.

Timeline

Start
2008-02-04
Primary completion
2008-09-12
Completion
2008-09-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Atorvastatin Small molecule 40 mg
Comparator Lamotrigine Small molecule 300 mg
Comparator Phenytoin Unknown 4 mg/kg

Indications